| |
| |
|
| Insider
Information: |
Stonehouse Jon P |
| Relationship: |
Director |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,298,856 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$5,018,354 |
|
|
|
Indirect Value
|
$91,400 |
|
|
| Total
Shares |
1,318,856 |
|
|
| Total
Value |
$5,109,754 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
President & CEO, Direc... |
2024-01-03 |
1,094,770 |
2024-01-03 |
20,000 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
204,086 |
2018-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2024-01-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,000 |
20,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2024-01-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
1,094,770 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-12-19 |
4 |
D |
$6.05 |
$85,238 |
D/D |
(14,089) |
1,114,770 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-12-14 |
4 |
D |
$6.43 |
$87,397 |
D/D |
(13,592) |
1,128,859 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
127,500 |
1,142,451 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-06-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
1,014,794 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-03-21 |
4 |
OE |
$3.22 |
$99,997 |
D/D |
31,055 |
1,039,794 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-02-01 |
4 |
AS |
$10.38 |
$1,038,000 |
D/D |
(100,000) |
1,008,739 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-02-01 |
4 |
OE |
$5.45 |
$545,000 |
D/D |
100,000 |
1,108,739 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
121,452 |
204,086 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
1,008,739 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
127,500 |
1,015,230 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-15 |
4 |
AS |
$10.90 |
$153,690 |
D/D |
(14,100) |
887,730 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-02 |
4 |
AS |
$12.80 |
$1,057,997 |
D/D |
(82,656) |
901,830 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-02 |
4 |
OE |
$1.42 |
$117,372 |
D/D |
82,656 |
984,486 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-01 |
4 |
AS |
$13.00 |
$2,793,921 |
D/D |
(214,917) |
901,830 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-01 |
4 |
OE |
$1.42 |
$305,182 |
D/D |
214,917 |
1,116,747 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,580 |
103,688 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-09-01 |
4/A |
OE |
$0.00 |
$0 |
D/D |
60,580 |
82,634 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-01-11 |
4 |
AS |
$15.04 |
$2,767,360 |
D/D |
(184,000) |
901,602 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-01-11 |
4 |
OE |
$4.73 |
$870,320 |
D/D |
184,000 |
1,085,602 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-01-04 |
4/A |
OE |
$0.00 |
$0 |
D/D |
21,054 |
22,054 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,504 |
22,504 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
123,000 |
901,602 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
